These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The prevalence of proteolytic antibodies against factor VIII in hemophilia A. Lacroix-Desmazes S; Bayry J; Misra N; Horn MP; Villard S; Pashov A; Stieltjes N; d'Oiron R; Saint-Remy JM; Hoebeke J; Kazatchkine MD; Reinbolt J; Mohanty D; Kaveri SV N Engl J Med; 2002 Feb; 346(9):662-7. PubMed ID: 11870243 [TBL] [Abstract][Full Text] [Related]
10. Hydrolysis of factor VIII mediated by catalytic antibodies occurs in haemophilia A patients with or without factor VIII inhibitors. Grosbois SS; Brionne MF; de Longcamp AL; Gautier P; V Kaveri S; Borel-Derlon A; Repessé Y Haemophilia; 2013 Mar; 19(2):322-9. PubMed ID: 23216758 [TBL] [Abstract][Full Text] [Related]
11. Autoantibodies with enzymatic properties in human autoimmune diseases. Wootla B; Lacroix-Desmazes S; Warrington AE; Bieber AJ; Kaveri SV; Rodriguez M J Autoimmun; 2011 Sep; 37(2):144-50. PubMed ID: 21624820 [TBL] [Abstract][Full Text] [Related]
12. Neutralisation of factor VIII inhibitors by anti-idiotypes isolated from phage-displayed libraries. Schmidt A; Brettschneider K; Kahle J; Orlowski A; Becker-Peters K; Stichel D; Schulze J; Braner M; Tampé R; Schwabe D; Königs C Thromb Haemost; 2016 Jul; 116(1):32-41. PubMed ID: 27009573 [TBL] [Abstract][Full Text] [Related]
13. Neutralizing antiidiotypic antibodies to factor VIII inhibitors after desensitization in patients with hemophilia A. Gilles JG; Desqueper B; Lenk H; Vermylen J; Saint-Remy JM J Clin Invest; 1996 Mar; 97(6):1382-8. PubMed ID: 8617869 [TBL] [Abstract][Full Text] [Related]
14. Proteolytic antibodies activate factor IX in patients with acquired hemophilia. Wootla B; Christophe OD; Mahendra A; Dimitrov JD; Repessé Y; Ollivier V; Friboulet A; Borel-Derlon A; Levesque H; Borg JY; Andre S; Bayry J; Calvez T; Kaveri SV; Lacroix-Desmazes S Blood; 2011 Feb; 117(7):2257-64. PubMed ID: 21131590 [TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated factor VIII gene expression results in attenuated anti-factor VIII-specific immunity in hemophilia A mice compared with factor VIII protein infusion. Bristol JA; Gallo-Penn A; Andrews J; Idamakanti N; Kaleko M; Connelly S Hum Gene Ther; 2001 Sep; 12(13):1651-61. PubMed ID: 11535168 [TBL] [Abstract][Full Text] [Related]
16. Induction of human factor VIII inhibitors in rats by immunization with human recombinant factor VIII: a small animal model for humans with high responder inhibitor phenotype. Jarvis MA; Levin LG; Harrison JA; DePianto DJ; Suzuki CM; Ziaja CL; Brown JE; Jolly KW; Reisner HM; Abildgaard CF; Powell JS Thromb Haemost; 1996 Feb; 75(2):318-25. PubMed ID: 8815584 [TBL] [Abstract][Full Text] [Related]
17. Distribution of Th1- and Th2-induced anti-factor VIII IgG subclasses in congenital and acquired hemophilia patients. Reding MT; Lei S; Lei H; Green D; Gill J; Conti-Fine BM Thromb Haemost; 2002 Oct; 88(4):568-75. PubMed ID: 12362225 [TBL] [Abstract][Full Text] [Related]
18. Factor VIII inhibitor with catalytic activity towards factor VIII. Lacroix-Desmazes S; Sooryanarayana ; Moreau A; Horn MP; Kazatchkine MD; Kaveri SV Chem Immunol; 2000; 77():102-14. PubMed ID: 11706701 [No Abstract] [Full Text] [Related]